PDF下载 ( 1782 KB)
The clinical characteristics and treatment of liver failure patients with spontaneous bacterial peritonitis
-
摘要: 目的分析肝衰竭合并自发性腹膜炎患者的临床特点及治疗疗效。方法回顾性研究201例肝硬化合并自发性腹膜炎患者,将其分为两组,分别为肝衰竭组及对照组,研究两组患者血常规、腹水细胞计数和腹水培养情况,进行t检验或χ2检验。对肝衰竭合并自发性腹膜炎患者中经验使用抗菌药物(三代头孢、莫西沙星、亚胺培南)的临床疗效进行分析。结果肝衰竭合并腹膜炎组患者血中中性粒细胞比例、PCT<2的比例、腹水细胞总数分别为(81.50±9.25)%、12.5%、(3.43±0.44)log/ml高于对照组(P<0.05)。两组腹水培养阳性率均较低,分别为22.7%及15.9%,两组间差异无统计学意义(P>0.05)。肝衰竭组腹水培养结果大肠杆菌所占比例为35.0%,对三代头孢普遍敏感率为25.0%,均低于对照组(分别为72.2%,66.7%),差异有统计学意义(P<0.05)。在肝衰竭合并腹膜炎组中应用亚安培南及莫西沙星治疗的有效率分别为84.0%、74.0%,高于三代头孢(52.6%),平均治疗时间分别为(7.10±1.64)d、(8.50±2.57)d短于三代头孢组(12.20±4.11)...Abstract: Objective To investigate the clinical characteristics and treatment of liver failure patients with spontaneous bacterial peritonitis (SBP) .Methods A total of 201 liver cirrhosis patients with SBP were retrospectively divided into liver failure group and control group.The complete blood count, ascites cell count and ascites culture were compared between the two groups.The curative effect of antibiotic therapy on liver failure patients with SBP was observed.Results The ratio of neutrophil, ratio of PCT < 2, and ascites cell count in liver failure group were higher than the non liver failure group (P < 0.05) .The positivity rates of ascites culture in both groups were lower.The positivity rate of Escherichia coli and the sensitivity to Moxifloxacin in liver failure group was lower than the control group (35.0% vs 72.2%, 25.0% vs 66.7%, P > 0.05) .The clinical effect of treatment with Imipenem trial and Moxifloxacin group were significantly higher than the Cephalosporin group (P < 0.05) .The treatment duration with Imipenem or Moxifloxacin was significantly shorter than that of Cephalosporin (P < 0.05) .Conclusion The disease severity is higher but the ascites culture positivity rate is lower in liver failure patients compared to the control group.The sensitivity to Moxifloxacin in liver failure group was lower.The curative effect of Imipenem and Moxifloxacin is better than Cephalosporins.
-
Key words:
- liver failure /
- peritonitis /
- liver cirrhosis
-
[1]van Erpecum KJ.Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis[J].Scand J Gastroenterol Suppl, 2006, (243) ∶79-84. [2]中华医学会.病毒性肝炎防治方案[J].传染病信息, 2000, 13 (4) ∶141-150. [3]中华医学会.肝衰竭诊治指南[J].中华肝脏病杂志, 2006, 14 (9) ∶643-645. [4]Rimola A, Garcia-Tsao G, Navasa M, et al.Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis:a consensus document[J].J Hepatol, 2000, 32 (1) ∶142-153. [5]Moore KP, Wong F, Gines P, et al.The management of ascites in cirrhosis:report on the consensus conference of the international ascite club[J].Hepatology, 2003, 38 (1) ∶258-266. [6]顾长海, 王宇明.肝功能衰竭[M].北京:人民卫生出版社, 2002, 381-386. [7]Wojtacha A, Juszczyk JC, Zarniak E, et al.Spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis based on bacteriological and biochemical results[J].Przegl Epidemiol, 2004, 58 (4) ∶597-607. [8]潘志刚, 陆才金, 苏东星, 等.肝硬化腹水并发自发性腹膜炎50例临床分析[J].内科, 2009, 4 (5) ∶717-718. [9]何卫平, 王慧芬, 苏海滨.77例肝衰竭患者医院感染败血症的临床研究[J].中华实验和临床病毒学杂志, 2004, 18 (3) ∶287-289. [10]Gary ES, Sharon S, Kerin LT, et al.Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra abdominal pathogens[J].Anaerobe, 2008, 14 (1) ∶8-12. -
本文二维码
计量
- 文章访问数: 3008
- HTML全文浏览量: 14
- PDF下载量: 694
- 被引次数: 0
下载:
